Back to Search
Start Over
Plasma exchange for COVID‐19 thrombo‐inflammatory disease
- Source :
- eJHaem, Vol 2, Iss 1, Pp 26-32 (2021)
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- Abstract Severe COVID‐19 disease is a hyperinflammatory, pro‐thrombotic state. We undertook plasma exchange (PEX) to determine its effects on organ function and thrombo‐inflammatory markers. Seven critically ill adults with severe COVID‐19 respiratory failure (PaO2:FiO2 ratio 800 IU/L and D‐dimer >1000 μg/L (or doubling from baseline) received PEX, daily, for a minimum of 5 days. No other immunomodulatory medications were initiated during this period. Seven patients matched for age and baseline biochemistry were a comparator group. Coagulation screening revealed no evidence of coagulopathy. However, von Willebrand Factor (VWF) activity, antigen and VWF antigen: ADAMTS13 ratio, Factor VIII and D‐dimers were all elevated. Following 5 days of PEX, plasma levels of all the above, and ferritin levels, were significantly reduced (P
Details
- Language :
- English
- ISSN :
- 26886146
- Volume :
- 2
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- eJHaem
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.43fb2ba29e694399b1dc8176e2fb3c76
- Document Type :
- article
- Full Text :
- https://doi.org/10.1002/jha2.140